Skip to content

VYCOR MEDICAL, INC.: 10-Q filed 2011-08-22

What VYCOR MEDICAL, INC. reported in its quarterly report filed 2011-08-22 (fiscal Q2 2011): 37 published measures, 93 facts as tagged in accession 0001145443-11-000826.

This filing

Form
10-Q (quarterly report)
Filed
2011-08-22
Fiscal period
fiscal Q2 2011
Accession
0001145443-11-000826 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All VYCOR MEDICAL, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2011-06-304,760,602USD
At 2010-12-312,153,694USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2011-06-302,816,966USD
At 2010-12-312,064,980USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2011-06-302,206,616USD
At 2010-12-31127,081USD
At 2010-06-30133,116USD
At 2009-12-3112,771USD

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2011-01-01 to 2011-06-30-1,401,297USD181
2010-01-01 to 2010-06-30-769,611USD181

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2011-01-01 to 2011-06-3016,071USD181
2010-01-01 to 2010-06-301,931USD181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2011-01-01 to 2011-06-303,556,194USD181
2010-01-01 to 2010-06-30889,500USD181

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2011-01-01 to 2011-06-30-75,866USD181
2010-01-01 to 2010-06-30456USD181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2011-06-30-9,654,121USD
At 2010-12-31-6,883,163USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2011-01-01 to 2011-06-30542USD181
2010-01-01 to 2010-06-302,078USD181

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2011-06-30711,662USD
At 2010-12-31773,188USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2011-01-01 to 2011-06-301,164,600USD181
2010-01-01 to 2010-06-30146,367USD181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2011-04-01 to 2011-06-30-1,805,712USD91
2011-01-01 to 2011-06-30-2,716,949USD181
2010-04-01 to 2010-06-30-408,388USD91
2010-01-01 to 2010-06-30-735,322USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2011-06-303,541,931USD
At 2010-12-31901,203USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2011-04-01 to 2011-06-3039,613USD91
2011-01-01 to 2011-06-3063,534USD181
2010-04-01 to 2010-06-3011,797USD91
2010-01-01 to 2010-06-3024,402USD181

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2011-06-301,500,604USD
At 2010-12-312,064,980USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2011-06-30233,010USD
At 2010-12-31114,447USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2011-06-30106,249USD
At 2010-12-3176,460USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2011-04-01 to 2011-06-301,912,851USD91
2011-01-01 to 2011-06-302,946,837USD181
2010-04-01 to 2010-06-30477,021USD91
2010-01-01 to 2010-06-30855,653USD181

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2011-06-3067,234USD
At 2010-12-3152,360USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2011-04-01 to 2011-06-30107,139USD91
2011-01-01 to 2011-06-30229,888USD181
2010-04-01 to 2010-06-3068,633USD91
2010-01-01 to 2010-06-30120,331USD181

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2011-04-01 to 2011-06-3037,484USD91
2011-01-01 to 2011-06-3061,336USD181
2010-04-01 to 2010-06-30762USD91
2010-01-01 to 2010-06-305,648USD181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2011-06-30804,985,775shares
At 2010-12-31724,488,929shares

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2011-06-30-20,092USD
At 2010-12-31-2,999USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2011-06-301,943,636USD
At 2010-12-3188,714USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2011-06-30514,934USD
At 2010-12-31406,998USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2011-06-301,161,832USD
At 2010-12-31645,302USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2011-04-01 to 2011-06-30-1,835,258USD91
2011-01-01 to 2011-06-30-2,770,416USD181
2010-04-01 to 2010-06-30-420,185USD91
2010-01-01 to 2010-06-30-759,724USD181

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2011-04-01 to 2011-06-30-1,835,258USD91
2011-01-01 to 2011-06-30-2,770,958USD181
2010-04-01 to 2010-06-30-420,185USD91
2010-01-01 to 2010-06-30-761,802USD181

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2011-04-01 to 2011-06-30866,838USD91
2011-01-01 to 2011-06-301,619,348USD181
2010-04-01 to 2010-06-30402,059USD91
2010-01-01 to 2010-06-30683,814USD181

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2011-01-01 to 2011-06-3017,989USD181
2010-01-01 to 2010-06-3011,571USD181

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2011-01-01 to 2011-06-3083,685USD181
2010-01-01 to 2010-06-308,253USD181

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2011-04-01 to 2011-06-30-29,546USD91
2011-01-01 to 2011-06-30-53,467USD181
2010-04-01 to 2010-06-30-11,797USD91
2010-01-01 to 2010-06-30-24,402USD181

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

PeriodValueUnitDays
2010-01-01 to 2010-06-302,078USD181

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2011-01-01 to 2011-06-30889,000USD181
2010-01-01 to 2010-06-30749,500USD181

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2011-01-01 to 2011-06-3029,592USD181
2010-01-01 to 2010-06-3032,864USD181

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2011-01-01 to 2011-06-3014,467USD181
2010-01-01 to 2010-06-3012,894USD181

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2011-01-01 to 2011-06-30116,485USD181
2010-01-01 to 2010-06-30-170,079USD181

Inspect the source

Entity
VYCOR MEDICAL, INC. / CIK 0001424768
Captured
2026-09-20T08:03:40.055Z
SEC response SHA-256
5a14e6ff2e4ebac913c15e977f951bb2964df57677e781dac80300af4dfd59db

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001424768.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))